1. Home
  2. JOE vs BEAM Comparison

JOE vs BEAM Comparison

Compare JOE & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JOE
  • BEAM
  • Stock Information
  • Founded
  • JOE 1936
  • BEAM 2017
  • Country
  • JOE United States
  • BEAM United States
  • Employees
  • JOE N/A
  • BEAM N/A
  • Industry
  • JOE Homebuilding
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JOE Real Estate
  • BEAM Health Care
  • Exchange
  • JOE Nasdaq
  • BEAM Nasdaq
  • Market Cap
  • JOE 2.7B
  • BEAM 2.3B
  • IPO Year
  • JOE N/A
  • BEAM 2020
  • Fundamental
  • Price
  • JOE $58.51
  • BEAM $22.21
  • Analyst Decision
  • JOE
  • BEAM Strong Buy
  • Analyst Count
  • JOE 0
  • BEAM 11
  • Target Price
  • JOE N/A
  • BEAM $49.40
  • AVG Volume (30 Days)
  • JOE 222.6K
  • BEAM 2.6M
  • Earning Date
  • JOE 10-29-2025
  • BEAM 11-04-2025
  • Dividend Yield
  • JOE 1.09%
  • BEAM N/A
  • EPS Growth
  • JOE 53.79
  • BEAM N/A
  • EPS
  • JOE 1.80
  • BEAM N/A
  • Revenue
  • JOE $488,689,000.00
  • BEAM $55,701,000.00
  • Revenue This Year
  • JOE N/A
  • BEAM N/A
  • Revenue Next Year
  • JOE N/A
  • BEAM $19.01
  • P/E Ratio
  • JOE $32.57
  • BEAM N/A
  • Revenue Growth
  • JOE 26.89
  • BEAM N/A
  • 52 Week Low
  • JOE $40.19
  • BEAM $13.53
  • 52 Week High
  • JOE $59.70
  • BEAM $35.25
  • Technical
  • Relative Strength Index (RSI)
  • JOE 71.89
  • BEAM 39.57
  • Support Level
  • JOE $58.08
  • BEAM $26.90
  • Resistance Level
  • JOE $59.70
  • BEAM $26.17
  • Average True Range (ATR)
  • JOE 1.87
  • BEAM 1.64
  • MACD
  • JOE 0.92
  • BEAM -0.69
  • Stochastic Oscillator
  • JOE 87.41
  • BEAM 8.35

About JOE St. Joe Company (The)

The St. Joe Co is a real estate development, asset management, and operating company and it has three operating segments; the Residential segment plans and develops residential communities and sells homesites to homebuilders or retail consumers, the Hospitality segment that derives maximum revenue, features a private membership club, hotel operations, food and beverage operations, golf courses, beach clubs, retail outlets, gulf-front vacation rentals, management services, marinas, and other entertainment assets, and Commercial segment include leasing of commercial property, multi-family, senior living, self-storage, and other assets and it also oversees the planning, development, entitlement, management, and sale of commercial and rural land holdings.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.

Share on Social Networks: